Rituxan (rituximab) - Roche
Clinical Features, Histopathology, and Outcomes of Fibrillary Glomerulonephritis: A Spanish Multicenter Cohort (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0866; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Baseline characteristics according to rituximab treatment Abbreviations: SD = standard deviation; eGFR = estimated glomerular filtration rate; Continuous variables are presented as mean ± SD or median (P25–P75), as appropriate. Categorical variables are presented as n (%)." 
Clinical • Glomerulonephritis • Lupus Nephritis • Nephrology • Renal Disease
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4559531
 
Efrain Tatis; Ines Maskani; Anna Domínguez Guasch; Candela Moliz; Fayna González Cabrera; Clara Maria Cases Corona; Josefa Belen Ferri; Sheila Cabello Pelegrin; Pablo J. Cannata-Ortiz; July Vanessa Osma; Natalia Santos Collado; José C. De La Flor; Ana Huerta; Fabrizzio Poma Saavedra; Catuxa Rodriguez Magariños; Javier Carbayo; Maria Jose Soler Romeo
 
Oct 2, 2026
 
Prev Next